In vitro diagnostics (IVDs) hold significant clinical value, but their accuracy, reliability, and safety directly impact medical decision-making. Therefore, strict adherence to relevant precautions is crucial during their use to ensure accurate test results and effective clinical application.
1. Sample Collection and Handling
Sample quality directly impacts the reliability of test results, so standard operating procedures (SOPs) must be strictly adhered to during collection, transportation, and storage. For example:
• Blood samples must avoid hemolysis, lipemia, or clots. The timing of blood collection and the choice of anticoagulant may affect test results.
• Body fluid samples (such as urine and cerebrospinal fluid) require careful collection procedures to avoid contamination or degradation.
• Sample storage conditions (such as temperature and storage time) must meet requirements. Some tests require high sample freshness.
2. Reagent and Instrument Selection and Validation
• Reagents should comply with national or international standards (such as those approved by the China National Medical Product Safety Administration (NMPA), the US Food and Drug Administration (FDA), and the EU CE certification) and be used within their expiration dates.
• Instrument calibration and maintenance should be performed regularly to ensure accurate and reproducible test results. • New reagents or methods should undergo performance validation before clinical application, including indicators such as precision, accuracy, sensitivity, and specificity.
3. Quality Control of the Testing Process
• Internal Quality Control (IQC): Laboratories should run quality control samples daily to monitor the stability of the testing system.
• External Quality Assessment (EQA): Participate in external quality assessment programs to ensure consistency of test results with those of other laboratories.
• Operating Standards: Testing personnel must receive professional training to avoid human errors, such as incorrect sample addition and improper instrument operation.
4. Interpretation of Results and Clinical Integration
• Reference Range: Reference intervals may vary for different populations (e.g., age, gender, and ethnicity) and should be interpreted in the context of the clinical setting.
• Cutoff Values and Gray Zones: Some test results may fall within the critical range and require further confirmation through additional testing or clinical follow-up.
• False Positives and False Negatives: Any test method may have errors. Clinicians must make comprehensive judgments and avoid relying solely on a single test result.
5. Regulatory and Ethical Compliance
• Compliance: In vitro diagnostic products must comply with national or regional regulatory requirements (e.g., China's "Regulations on the Registration and Administration of In Vitro Diagnostic Reagents").
• Data Security: Test data involving patient privacy must be strictly protected and comply with relevant laws and regulations (e.g., the "Personal Information Protection Law").
• Ethical Review: Certain specialized tests (e.g., genetic testing) must adhere to ethical standards to ensure informed consent and appropriate data use.
Conclusion
In vitro diagnostics are an indispensable tool in modern medicine. Their development and application have greatly improved the efficiency and accuracy of disease diagnosis. However, the reliability of IVDs depends on sample quality, reagent and instrument performance, rigorous quality control procedures, and accurate interpretation of results. Medical institutions and testing personnel must fully understand the precautions for IVDs to ensure the accuracy of test results, thereby providing reliable support for clinical decision-making and ultimately improving patient diagnosis and treatment outcomes.